The authors write "A recent court decision appears to be the first reported case that addresses an interesting question – ...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

USAA has agreed to a $3.25 million class action settlement to resolve claims that it failed to prevent a 2021 data breach ...

The owner of a Waco construction company who sold $8 million worth of bank stock to a trust established by State Rep. Pat ...

In a move that may clear the path for app stores to exert more control over deleting third-party apps, a California federal ...

Takeaway: Former FBI Director Robert Mueller once famously said, “There are only two types of companies: those that have been hacked and those ...

In a recent article, I described the specific doctrinal, social, and informational dynamics that both render such contracts vulnerable to breach and frustrate their enforcement. This Article ...

J&J said it is seeking a preliminary injunction for Samsung Bioepis' Stelara biosimilar over an unauthorized sublicense deal ...

Johnson & Johnson (JNJ.N), opens new tab sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to Stelara, J&J's blockbuster psoriasis treatment.